"Wearing-off" efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials.
Thanin AsawavichienjindaSeelwan SathitratanacheewinRonpichai ChokesuwattanaskulPublished in: Cephalalgia : an international journal of headache (2023)
In this meta-analysis, there was a wearing-off efficacy of galcanezumab but only in a small percentage of patients with chronic migraine in randomized controlled trials.